Cell Cycle/Checkpoint
Cell Cycle
Cells undergo a complex cycle of growth and division that is referred to as the cell cycle. The cell cycle consists of four phases, G1 (GAP 1), S (synthesis), G2 (GAP 2) and M (mitosis). DNA replication occurs during S phase. When cells stop dividing temporarily or indefinitely, they enter a quiescent state called G0.
Research Areas
- ATM/ATR(26)
- Aurora Kinase(29)
- Cdc42(4)
- Cdc7(3)
- Chk(13)
- c-Myc(38)
- CRM1(8)
- Cyclin-Dependent Kinases(70)
- E1 enzyme(1)
- G-quadruplex(13)
- Haspin(5)
- HMTase(1)
- Kinesin(29)
- Ksp(4)
- Microtubule/Tubulin(272)
- Mps1(14)
- Mitotic(7)
- RAD51(13)
- ROCK(72)
- Rho(13)
- PERK(16)
- PLK(46)
- PTEN(7)
- Wee1(11)
- PAK(28)
- Arp2/3 Complex(10)
- Dynamin(16)
- ECM & Adhesion Molecules(53)
- Cholesterol Metabolism(10)
- Endomembrane System & Vesicular Trafficking(34)
- G1(50)
- G2/M(35)
- G2/S(16)
- Genotoxic Stress(22)
- Inositol Phosphates(65)
- Proteolysis(179)
- Cytoskeleton & Motor Proteins(68)
- Cellular Chaperones(14)
- Cyclin G-associated Kinase (GAK)(2)
- MARK(4)
- NEKs(6)
- ATF6(2)
- ClpP(4)
- Disulfidptosis(1)
- HMG Family(1)
- PDI(1)
- SWI/SNF Complex(4)
- VISTA(2)
- HOXA(1)
Products Related to Cell Cycle/Checkpoint(1447)
- GC79143BRD4-IN-12CAS: 3112325-99-9Purity: >98%
BRD4-IN-12 is a potent and orally active BRD4 inhibitor with an IC 50 of 7.9 nM.
- GC79976Chitosan oligosaccharide (MW 2000)Purity: >98.00%
Chitosan oligosaccharide (MW 2000) is a natural oligomer derived from chitosan, with a molecular weight of 2000 Da.
- GC79994Cy5-Paclitaxel bromidePurity: >92.50%
Cy5-Paclitaxel bromide is a fluorescently labeled drug probe formed by conjugating the fluorescent dye Cy5 (Cyanine 5) with the chemotherapeutic agent Paclitaxel, which is used to track the cellular uptake, subcellular distribution and drug delivery process of Paclitaxel.
- GC80850Gartisertib-d 8CAS: 1792214-00-6Purity: >98%
Gartisertib -d 8 (VX-803-d 8 ) is the deuterium labeled Gartisertib.
- GC80888PROTAC PLK1 Degrader-2Purity: >99.00%
PROTAC PLK1 Degrader-2 is a peptide-based N-end rule PLK1 mini-PROTAC.
- GC80890NEK7 degrader-3CAS: 3119435-52-5Purity: >98%
NEK7 degrader-3 is an orally active and brain-penetrant NEK7 molecular glue degrader with a DC 50 of 33.1 nM.
- GC80891NK7-902 diTFAPurity: >99.50%
NK7-902 diTFA is a selective and orally active CRBN-dependent NEK7 molecular glue degrader with K d values of 1.5 and 2.6 μM for hNEK7 and mNEK7.
- GC80896PROTAC D16-M1P2Purity: >98%
PROTAC D16-M1P2 is an orally active CRBN -mediated selective PKMYT1 PROTAC degrader, with a DC 50 of 0.7 nM in CCNE1-amplified HCC1569 breast cancer cells.
- GC80919AURKA-IN-4CAS: 89575-11-1Purity: >99.50%
AURKA-IN-4 is a Capsaicin -derived molecular glue targeting AURKA-PHB2, and acts as an inhibitor of Aurora kinase A ( AURKA ) and PHB2.
- GC81431(S,S,S)-Icafolin-methylCAS: 2254813-53-9Purity: >99.50%
(S,S,S)-Icafolin-methyl is an isomer of Icafolin-methyl.
- GC81434RAS activator compound 1CAS: 1579978-17-8Purity: >98.50%
RAS activator compound 1 (Compound 7c) is a RAS activator targeting the guanine nucleotide exchange factor (GEF) son of sevenless homologue 1 ( SOS1 ).
- GC814672,6-Dibromo-4-(hydroxymethyl)phenolCAS: 2316-62-3Purity: >98.00%
2,6-Dibromo-4-(hydroxymethyl) phenol (Compound 5) acts as a selective inhibitor of Saccharomyces cerevisiae glucose-6-phosphate dehydrogenase, with an IC 50 value of 50.2 μM, and shows no activity against Leuconostoc mesenteroides glucose-6-phosphate dehydrogenase [1] .
- GC81479SMARCA2-IN-10CAS: 82131-85-9Purity: >96.00%
SMARCA2-IN-10 (Compound 4) is a highly selective SMARCA2 ATPase domain inhibitor ( IC 50 =17.676 μM).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79143 | BRD4-IN-12 | 3112325-99-9 | >98% | |
BRD4-IN-12 is a potent and orally active BRD4 inhibitor with an IC 50 of 7.9 nM. | ||||
| GC79149 | WX2-43 | 723754-14-1 | >99.00% | |
WX2-43 is a PRMT5-KLF4 inhibitor ( K d of 11.0 nM). | ||||
| GC79976 | Chitosan oligosaccharide (MW 2000) | - | >98.00% | |
Chitosan oligosaccharide (MW 2000) is a natural oligomer derived from chitosan, with a molecular weight of 2000 Da. | ||||
| GC79994 | Cy5-Paclitaxel bromide | - | >92.50% | |
Cy5-Paclitaxel bromide is a fluorescently labeled drug probe formed by conjugating the fluorescent dye Cy5 (Cyanine 5) with the chemotherapeutic agent Paclitaxel, which is used to track the cellular uptake, subcellular distribution and drug delivery process of Paclitaxel. | ||||
| GC80482 | Carba1 | 2635394-10-2 | >98.00% | |
Carba1 is a bifunctional Carbazole derivative that activates nicotinamide phosphoribosyltransferase ( NAMPT ) and enhances NAD biosynthesis. | ||||
| GC80850 | Gartisertib-d 8 | 1792214-00-6 | >98% | |
Gartisertib -d 8 (VX-803-d 8 ) is the deuterium labeled Gartisertib. | ||||
| GC80874 | ARN25699 | - | >98% | |
ARN25699 is a kinase inhibitor with an IC 50 of 5.5 nM against GSK-3β, 2.2 nM against FYN-α, and 242.3 nM against DYRK1A, and it exhibits oral bioavailability. | ||||
| GC80888 | PROTAC PLK1 Degrader-2 | - | >99.00% | |
PROTAC PLK1 Degrader-2 is a peptide-based N-end rule PLK1 mini-PROTAC. | ||||
| GC80890 | NEK7 degrader-3 | 3119435-52-5 | >98% | |
NEK7 degrader-3 is an orally active and brain-penetrant NEK7 molecular glue degrader with a DC 50 of 33.1 nM. | ||||
| GC80891 | NK7-902 diTFA | - | >99.50% | |
NK7-902 diTFA is a selective and orally active CRBN-dependent NEK7 molecular glue degrader with K d values of 1.5 and 2.6 μM for hNEK7 and mNEK7. | ||||
| GC80896 | PROTAC D16-M1P2 | - | >98% | |
PROTAC D16-M1P2 is an orally active CRBN -mediated selective PKMYT1 PROTAC degrader, with a DC 50 of 0.7 nM in CCNE1-amplified HCC1569 breast cancer cells. | ||||
| GC80916 | ZX079 | 3124583-65-6 | >98% | |
ZX079 is a dual BRD4 and CBP PROTAC degrader with a BRD4 DC 50 value of 0.035 nM and a CBP DC 50 value of < 0.02 nM. | ||||
| GC80919 | AURKA-IN-4 | 89575-11-1 | >99.50% | |
AURKA-IN-4 is a Capsaicin -derived molecular glue targeting AURKA-PHB2, and acts as an inhibitor of Aurora kinase A ( AURKA ) and PHB2. | ||||
| GC80921 | CCT400028 | - | >98.00% | |
CCT400028 is a PROTACs -class degrader that targets the Aurora A (AURKA) kinase. | ||||
| GC80928 | NP1192 | 2966791-41-1 | >99.00% | |
NP1192 is a potent, selective PROTAC NAT10 degrader. | ||||
| GC80940 | dIRF4-2 | 3136609-62-3 | >99.00% | |
dIRF4-2 is a selective IRF4 PROTAC degrader with a DC 50 value of 2.2 μM. | ||||
| GC81431 | (S,S,S)-Icafolin-methyl | 2254813-53-9 | >99.50% | |
(S,S,S)-Icafolin-methyl is an isomer of Icafolin-methyl. | ||||
| GC81434 | RAS activator compound 1 | 1579978-17-8 | >98.50% | |
RAS activator compound 1 (Compound 7c) is a RAS activator targeting the guanine nucleotide exchange factor (GEF) son of sevenless homologue 1 ( SOS1 ). | ||||
| GC81443 | E8431 | 2419580-01-9 | >97.00% | |
E8431 is a DCSTAMP antagonist with an IC 50 value of 775.8 nM for osteoclastogenesis. | ||||
| GC81460 | BTX-6654 formate | - | >98.50% | |
BTX-6654 formate is a SOS1 PROTAC degrader. | ||||
| GC81467 | 2,6-Dibromo-4-(hydroxymethyl)phenol | 2316-62-3 | >98.00% | |
2,6-Dibromo-4-(hydroxymethyl) phenol (Compound 5) acts as a selective inhibitor of Saccharomyces cerevisiae glucose-6-phosphate dehydrogenase, with an IC 50 value of 50.2 μM, and shows no activity against Leuconostoc mesenteroides glucose-6-phosphate dehydrogenase [1] . | ||||
| GC81468 | MS102 | 3058587-77-9 | >98% | |
MS102 is an orally active ubiquitin specific peptidase 2 ( USP2 ) inhibitor with an IC 50 of 5.46 μM. | ||||
| GC81479 | SMARCA2-IN-10 | 82131-85-9 | >96.00% | |
SMARCA2-IN-10 (Compound 4) is a highly selective SMARCA2 ATPase domain inhibitor ( IC 50 =17.676 μM). | ||||
| GC81480 | FHD-909 | 3008577-34-9 | >98% | |
FHD-909 (LY4050784) is an orally active and selective SMARCA2 (BRM) ATPase inhibitor. | ||||
